Rabipur: A reliable vaccine for rabies protection

Vaccine

Volumn 17, Issue 13-14, 1999, Pages 1739-1741

  Vodopija, Ivan ^a   Baklaić, Željko ^a   Vodopija, Radovan ^a  

^a Zagreb Institute of Public Health   (Croatia)

Author keywords

Immunization; Rabies; Rabipur

Indexed keywords

RABIES VACCINE;

CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; IMMUNOGENICITY; PRIORITY JOURNAL; RABIES; VACCINATION;

ADULT; ANIMALS; CHICK EMBRYO; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; RABIES; RABIES VACCINES;

EID: 0344572872     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00427-7     Document Type: Conference Paper

References (9)

1. Kositprapa C., Wimalratna O., Chomchey P.et al. Problems with rabies postexposure management: a survey of 499 public hospitals in Thailand. J. Travel Med. 5:1988;30-32.
2. Bijok U. Purified chick embryo cell (PCEC) rabies vaccine: a review of clinical development 1982-1984. In: Vodopija I, Nicholson KG, Smerdel S, Bijok U, editors. Improvements in rabies postexposure treatment. Zagreb: Zagreb Institute of Public Health, 1985. p. 103-14.
3. Seghal S., Bhattacharya D., Bhardway M. Ten years longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and postexposure prophylaxis of rabies in Indian population. J. Com. Dis. 27(4):1995;36-43.
4. Wasi C., Chaiprasithikul P., Auewarakul P.et al. The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment. Southeast Asian J. Trop. Med. Public Health. 24(3):1993;461-466.
5. WHO Expert Committee on Rabies. Eight report. Technical Report Series 824. Geneva: WHO, 1992.
6. Vodopija I., Sureau P., Smerdel S.et al. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vaccine. 6:1988;283-286.
7. Zalan E., Wilson S., Pukitis D.A. A microtest for the quantitation of rabies virus neutralizing antibodies. J. Biol. Stand. 7:1979;213-220.
8. Vodopija R., Lafont M., Baklaic Z.et al. Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine. Vaccine. 15(5):1997;571-574.
9. Dietzschold B, Hooper C. Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain SHBRV. Vaccine 1998;16, in press.